Hematopoietic peripheral circulating blood stem cells as an independent marker of good transfusion management in patients with β-thalassemia: results from a preliminary study
- Authors: Napolitano, M.; Gerardi, C.; Di Lucia, A.; Accardo, P.; Rizzuto, L.; Ferraro, M.; Siragusa, S.; Buscemi, F.
- Publication year: 2016
- Type: Articolo in rivista (Articolo in rivista)
- Key words: Peripheral CD34+ stem cells, beta-thalassemia
- OA Link: http://hdl.handle.net/10447/168786
Abstract
Beyond hemoglobin (Hb) levels and performance status, further surrogate markers of appropriate transfusion management should improve the quality of thalassemia care. We investigated the levels of peripheral circulating CD34+ stem cells as an independent marker of appropriate hematopoietic balance in patients with thalassemia.